Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Calcitriol

Trial Locations (16)

9000

UZ Gent Dermatology Department, Ghent

10117

Charité Universitätsmedizin Berlin, Berlin

10467

Montefiore Medical Center, New York

33612

University of South Florida, Tampa

35128

Padova University Hospital, Padua

43126

University of Parma, Parma

46032

Shideler Clinical Research Center, Carmel

46256

Dawes Fretzin Clinical Research Group, Indianapolis

55131

Universitäts-Hautklinik Mainz, Johannes Gutenberg-Universität Mainz, Mainz

72758

Northwest Arkansas Clinical Trials Center, PLLC, Rogers

72916

Johnson Dermatology, Fort Smith

76011

Arlington Research Center for Dermatology, Arlington

91505

Advanced Skincare Surgery & Medcenter, Burbank

L3P1X2

Lynderm Research Inc., Markham

H3T1C5

CHU Sainte-Justine, Montreal

01307

University Hospital Carl Gustav Carus, Dresden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY